Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/17236
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChua, Chong Chyn-
dc.contributor.authorLim, Hui Yin-
dc.contributor.authorChai, Khai Li-
dc.contributor.authorOng, Jeremy-
dc.contributor.authorSim, Shirlene-
dc.contributor.authorWood, Colin-
dc.contributor.authorDickinson, Michael-
dc.contributor.authorCampbell, Philip-
dc.contributor.authorHempton, Jennifer-
dc.contributor.authorKing, Hayley-
dc.contributor.authorDowsing, Claire-
dc.contributor.authorBergin, Krystal-
dc.contributor.authorMuir, Sharon-
dc.contributor.authorGibbs, Simon-
dc.contributor.authorGrigg, Andrew P-
dc.date2018-03-09-
dc.date.accessioned2018-03-21T02:16:41Z-
dc.date.available2018-03-21T02:16:41Z-
dc.date.issued2018-09-
dc.identifier.citationBone marrow transplantation 2018; 53(9): 1116-1123-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/17236-
dc.description.abstractBortezomib-based induction is often used in transplant-eligible patients with myeloma. The optimal peripheral blood stem cell (PBSC) mobilisation strategy in this context is unclear. We reviewed the efficacy of G-CSF alone (G-alone) vs. G-CSF and cyclophosphamide (G-cyclo: standard dose: 1.5-2 g/m2; high dose: 3-4 g/m2) PBSC mobilisation strategies in 288 patients who only received bortezomib, cyclophosphamide and dexamethasone (VCD) induction prior to autograft across six apheresis centres from November 2012 to June 2017. 'Uncomplicated successful mobilisation' was defined as achieving a PBSC yield of ≥4 × 106/kg within two aphereses, without plerixafor or mobilisation-associated toxicity (predominantly febrile neutropenia, FN). Success rates were 84% in G-cyclo standard dose (6% FN), 64% in G-cyclo high dose (18% FN) and 69% in G-alone (plerixafor successfully salvaged 8/9 patients). Median total stem cell yield was significantly higher with G-cyclo, but not different between the two cyclophosphamide doses. Age greater than the median of 61 years was associated with higher failure rates (22 vs. 11%, p = 0.01) and lower PBSC yield, especially in the G-alone group. Prior radiotherapy exposure did not impact on collection success. Our observations suggest that both G-cyclo standard dose and G-alone are reasonable mobilisation strategies. The former may be preferred if salvage plerixafor is unavailable.-
dc.language.isoeng-
dc.titlePeripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myeloma.-
dc.typeJournal Article-
dc.identifier.journaltitleBone marrow transplantation-
dc.identifier.affiliationClinical Haematology, Austin Health, Heidelberg, Victoria, Australia-
dc.identifier.affiliationClinical Haematology, St Vincent's Health, Fitzroy, Victoria, Australia-
dc.identifier.affiliationIntegrated Haematology Department, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Parkville, Victoria, Australia-
dc.identifier.affiliationThe Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia-
dc.identifier.affiliationClinical Haematology, Cancer Services Barwon Health- University Hospital, Geelong, Victoria, Australia-
dc.identifier.affiliationDeakin University School of Medicine, Geelong, Victoria, Australia-
dc.identifier.affiliationClinical Haematology, Alfred Health-Monash University, Clayton, Victoria, Australia-
dc.identifier.affiliationDepartment of Haematology, Monash University Eastern Health Clinical School, Clayton, Victoria, Australia-
dc.identifier.doi10.1038/s41409-018-0152-2-
dc.identifier.orcid0000-0002-2162-3288-
dc.identifier.pubmedid29523889-
dc.type.austinJournal Article-
local.name.researcherChua, Chong Chyn
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
crisitem.author.deptClinical Haematology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptClinical Haematology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

16
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.